脉络膜成像生物标志物预测新生血管性年龄相关性黄斑变性对抗VEGF治疗的高反应与抵抗
该回顾性研究分析新生血管性年龄相关性黄斑变性患者,比较高强度抗VEGF方案组(n=25)与低强度方案组(n=20)的OCT脉络膜参数。多因素逻辑回归显示,较厚的中心凹下脉络膜厚度和较大的总脉络膜面积是抗VEGF治疗反应差的显著预测因素。
要点
- 中心凹下脉络膜厚度较厚和总脉络膜面积较大与抗VEGF治疗反应差显著相关。
- 两组基线年龄、性别、视网膜假性玻璃膜疣、PCV特征、CNV类型及地图样萎缩无显著差异。
- 脉络膜血管指数、管腔面积、毛细血管层及Haller/Sattler层厚度未显示显著预测价值。
核心结论
- 较厚的中心凹下脉络膜厚度和较大的总脉络膜面积是预测抗VEGF治疗反应差的有用变量。
研究设计与样本
- 回顾性综述,纳入三级研究所接受新生血管性年龄相关性黄斑变性治疗的患者,高强度方案组n=25,低强度方案组n=20。
主要发现
- 多因素逻辑回归显示较厚中心凹下脉络膜厚度(E=0.02;P=0.02)和较大总脉络膜面积(E=1.82;P=0.0075)是抗VEGF治疗反应差的显著预测因素。
- 两组基线年龄、性别、视网膜假性玻璃膜疣发生率、OCT上PCV特征、CNV膜类型及地图样萎缩无显著差异。
关键数值与推荐
- 高强度方案定义为长期抗VEGF治疗中无法将注射间隔延长至超过1个月且需要双倍药物剂量(n=25)。
- 低强度方案定义为至少3次注射后进入长期缓解且至末次访视保持干燥超过1年(n=20)。
临床怎么用
- 临床可参考中心凹下脉络膜厚度和总脉络膜面积识别可能对抗VEGF标准方案反应差的新生血管性AMD患者。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
PURPOSE: To determine structural predictors of treatment response in neovascular age-related macular degeneration analyzing optical coherence tomography (OCT)-related biomarkers. METHODS: A retrospective review of patients undergoing treatment for neovascular age-related macular degeneration at a tertiary institute was performed at presentation. High-intensity regimen included eyes on long-term anti-vascular endothelial growth factor treatment with the inability to extend beyond a month without a relapse and needed double the dose of medication (n = 25). Low-intensity regimen had eyes that went into long-term remission after at least three injections and remained dry for more than a year until the last visit (n = 20). Multimodal imaging including fluorescein angiogram, OCT, and comprehensive ocular evaluation were done. Choroidal vascularity index, total choroidal area, luminal area, subfoveal choroidal thickness, choriocapillaris thickness and Haller and Sattler layer thickness were analyzed for statistical significance. RESULTS: The groups had no significant difference at baseline in age, gender, incidence of reticular pseudodrusen, polypoidal choroidal vasculopathy feature on OCT, type of choroidal neovascular membrane, and geographic atrophy. Multinomial logistic regression revealed that thicker subfoveal choroidal thickness and larger total choroidal area were the significant predictors of poor response to anti-vascular endothelial growth factor treatment (E = 0.02; P = 0.02; E = 1.82; P = 0.0075). CONCLUSION: Thicker subfoveal choroidal thickness and higher total choroidal area are useful variables to predict a poor treatment response.
引用
- Jhingan M, Cavichini M, Amador M, et al. CHOROIDAL IMAGING BIOMARKERS TO PREDICT HIGHLY RESPONSIVE AND RESISTANT CASES TREATED WITH STANDARDIZED ANTI-VASCULAR ENDOTHELIAL GROWTH FACTOR REGIMEN IN NEOVASCULAR AGE-RELATED MACULAR DEGENERATION. Retina. 2021. PMID: 34543243. doi:10.1097/IAE.0000000000003156
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。